This is the third vial from the same lot, so I can compare against two known-good ones. I would like the arithmetic checked rather than the conclusion asserted. I…
Top voted questions
Highest-scoring questions on the site.
The label documentation for the agent in question is ambiguous on exactly this point. The figures are clear enough; the question is what they mean and what they do…
Stated plainly: 74 kg · 900 kcal. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…
Conditions: SURMOUNT-4 · 5 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Concretely: orforglipron · room temperature. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
Setup, so nobody has to ask: 98.2% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the…
The specifics, since they change the answer: tirzepatide · 2.5 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two…
What I have: a GLP-1 receptor agonist · sixteen weeks · minus 20 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
The specifics, since they change the answer: +4 · 3751.0 Da. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers…
The particulars: a Karl Fischer water content test · oral semaglutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I…
The case in front of me: PIONEER-4 · 7 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The case in front of me: nausea · tirzepatide · SURMOUNT-2. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
The case in front of me: 95.2% · VendorInvestigate · 97.9%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
Stated plainly: minus 80 °C · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
Stated plainly: ALT · mazdutide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background is…
This came up because two published schedules for the same agent differ. I would like help reading this properly rather than being told what conclusion to reach. I…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
Setup, so nobody has to ask: 95.2% · Medutest · 96.8% · Janoshik. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
I am comparing a supplier certificate against an independent result on the same lot. The empirical answer seems settled. The explanation does not. If the honest…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
The case in front of me: ferritin · oral semaglutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the…
Details up front: 1.7 mg · sixteen weeks · reflux. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Conditions: Homopeptide · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The specifics, since they change the answer: Medutest · Xi’an Mokemei Biotechnology. I have read the primary source rather than the summary, which has left me with…